NO931413D0 - Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer - Google Patents

Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer

Info

Publication number
NO931413D0
NO931413D0 NO931413A NO931413A NO931413D0 NO 931413 D0 NO931413 D0 NO 931413D0 NO 931413 A NO931413 A NO 931413A NO 931413 A NO931413 A NO 931413A NO 931413 D0 NO931413 D0 NO 931413D0
Authority
NO
Norway
Prior art keywords
treatment
methods
cell proliferation
preparations
proliferation diseases
Prior art date
Application number
NO931413A
Other languages
English (en)
Other versions
NO931413L (no
Inventor
Lawrence M Blatt
Milton W Taylor
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO931413L publication Critical patent/NO931413L/no
Publication of NO931413D0 publication Critical patent/NO931413D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO931413A 1990-10-17 1993-04-16 Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer NO931413D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59920690A 1990-10-17 1990-10-17
US77292291A 1991-10-15 1991-10-15
PCT/US1991/007722 WO1992006707A1 (en) 1990-10-17 1991-10-15 Methods and compositions for the treatment of cell proliferation disorders

Publications (2)

Publication Number Publication Date
NO931413L NO931413L (no) 1993-04-16
NO931413D0 true NO931413D0 (no) 1993-04-16

Family

ID=27083273

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931413A NO931413D0 (no) 1990-10-17 1993-04-16 Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer

Country Status (17)

Country Link
EP (1) EP0553294B1 (no)
JP (1) JP3496937B2 (no)
CN (1) CN1053117C (no)
AT (1) ATE174798T1 (no)
AU (1) AU660633B2 (no)
CA (1) CA2094275C (no)
DE (1) DE69130679T2 (no)
DK (1) DK0553294T3 (no)
ES (1) ES2128348T3 (no)
HK (1) HK1010340A1 (no)
IE (1) IE913656A1 (no)
IL (1) IL99778A (no)
NO (1) NO931413D0 (no)
NZ (1) NZ240264A (no)
PT (1) PT99265B (no)
SG (1) SG52537A1 (no)
WO (1) WO1992006707A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US5372808A (en) * 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
WO1995015177A2 (en) * 1993-12-02 1995-06-08 President And Fellows Of Harvard College Improved efficacy of alpha-helical cytokines
US20030053982A1 (en) 1994-09-26 2003-03-20 Kinstler Olaf B. N-terminally chemically modified protein compositions and methods
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5824789A (en) * 1995-06-07 1998-10-20 Systemix, Inc. Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof
US6013253A (en) * 1997-08-15 2000-01-11 Amgen, Inc. Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
US7232805B2 (en) * 2003-09-10 2007-06-19 Inflabloc Pharmaceuticals, Inc. Cobalamin conjugates for anti-tumor therapy
US7220407B2 (en) 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
WO2005113592A2 (en) 2004-05-19 2005-12-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
EP2749290A3 (en) * 2005-03-09 2015-02-18 Guangwen Wei Uses of recombinant super-compound interferons
BRPI0609809A2 (pt) 2005-05-18 2011-10-11 Maxygen Inc polipeptìdeo isolado ou recombinante, conjugado, composição, polinucleotìdeo isolado ou recombinante, célula hospedeira, vetor, métodos para preparar o polipeptìdeo, para preparar um conjugado, para inibir replicação de um vìrus em células infectadas com o vìrus para reduzir o numero de cópias de um vìrus em células infectadas com o vìrus, para reduzir o nìvel de rna de hcv no soro de um paciente infectado com hcv, para reduzir o nìvel de dna de hbv em soro de um paciente infectado com hbv e para reduzir o nìvel de rna de hiv em soro de um paciente infectado com hiv, e, uso do polipeptìdeo ou do conjugado

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4879471A (en) * 1987-03-25 1989-11-07 Measurex Corporation Rapid-scanning infrared sensor

Also Published As

Publication number Publication date
IL99778A0 (en) 1993-02-21
NO931413L (no) 1993-04-16
PT99265A (pt) 1992-08-31
CA2094275C (en) 2003-06-03
AU660633B2 (en) 1995-07-06
EP0553294A1 (en) 1993-08-04
ATE174798T1 (de) 1999-01-15
ES2128348T3 (es) 1999-05-16
DE69130679D1 (de) 1999-02-04
NZ240264A (en) 1997-07-27
DE69130679T2 (de) 1999-05-06
WO1992006707A1 (en) 1992-04-30
JPH06502426A (ja) 1994-03-17
CN1064018A (zh) 1992-09-02
EP0553294A4 (en) 1994-11-23
HK1010340A1 (en) 1999-06-17
PT99265B (pt) 1999-04-30
EP0553294B1 (en) 1998-12-23
CA2094275A1 (en) 1992-04-18
CN1053117C (zh) 2000-06-07
SG52537A1 (en) 1998-09-28
DK0553294T3 (da) 1999-08-23
AU9023591A (en) 1992-05-20
IE913656A1 (en) 1992-04-22
IL99778A (en) 1996-11-14
JP3496937B2 (ja) 2004-02-16

Similar Documents

Publication Publication Date Title
NO943901D0 (no) Fremgangsmåter og preparater for behandling av sykdommer med interferon samtidig som bivirkninger reduseres
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
NO883896L (no) Fremgangsmaate til fremstilling av konjugater av cytokinermed menneskelig immunglobulin.
NO307031B1 (no) Farmasøytiske produkter for legning av tumorsykdommer, og fremgangsmåte for fremstilling av disse
ZA91574B (en) Use of n-myristoyl-(s)-phenylalanine for obtaining medicinal products for the treatment of diseases involving myristoylation
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
NO931413L (no) Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
DE69426334T2 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
DK360884A (da) Farmaceutiske og veterinaere midler til behandling af iskaemiskehjertelidelser
NO973193D0 (no) Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer
DK0859630T3 (da) Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer
DE3374066D1 (en) N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor
ITMI911206A0 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari
DK0427633T3 (da) Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer
SE9003140D0 (sv) Method and composition for treatment of heart diseases
NO923078D0 (no) Skumbar sammensetning for farmasoeytisk anvendelse, anvendelse derav og fremgangsmaate for behandling
IT8422685A0 (it) Composizione farmaceutica eprocedimento per il trattamento di eccetazione psicomotoria.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application